UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Segmental arterial mediolysis and its mimickers: a case report and review of the literature

European journal of case reports in internal medicine, 2023-10, Vol.10 (11), p.004085-004085

2023

Volltextzugriff (PDF)

Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection

Inflammatory bowel diseases, 2007-02, Vol.13 (2), p.135-142

2007

Volltextzugriff (PDF)

Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases

Inflammatory bowel diseases, 2018-06, Vol.24 (7), p.1428-1439

2018

Volltextzugriff (PDF)

Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study

Inflammatory bowel diseases, 2024-01

2024

Volltextzugriff (PDF)

Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection

2007-02

Volltextzugriff (PDF)

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis

Gut, 2023-11, Vol.72 (11), p.2068-2080

2023

Volltextzugriff (PDF)

Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases

Inflammatory bowel diseases, 2022-02, Vol.28 (2), p.208-217

2022

Volltextzugriff (PDF)

Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID

Alimentary Pharmacology & Therapeutics (Suppl), 2021-05, Vol.53 (10), p.1098-1107

2021

Volltextzugriff (PDF)

A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103− dendritic cells

The Journal of experimental medicine, 2009-08, Vol.206 (9), p.1995-2011

2009

Volltextzugriff (PDF)

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

The FASEB journal, 2002-01, Vol.16 (1), p.61-71

2002

Volltextzugriff (PDF)

Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

United European gastroenterology journal, 2019-07, Vol.7 (6), p.750-758

2019

Volltextzugriff (PDF)

Abstract 4603: Clinical application and potential usefulness of targeted next-generation sequencing on resected pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4603-4603

2018

Volltextzugriff (PDF)

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

Acta gastro-enterologica belgica, 2018-01, Vol.81 (1), p.49-53

2018

Volltextzugriff (PDF)

CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF

The Journal of experimental medicine, 2013-06, Vol.210 (6), p.1251-1263

2013

Volltextzugriff (PDF)

Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters

Gut microbes, 2022-12, Vol.14 (1), p.1275-1283

2022

Volltextzugriff (PDF)

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists

United European gastroenterology journal, 2018-04, Vol.6 (3), p.439-445

2018

Volltextzugriff (PDF)

Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response

GastroHep, 2021-03, Vol.3 (2), p.63-71

2021

Volltextzugriff (PDF)

Inhibition of Th1 Immune Response by Glucocorticoids: Dexamethasone Selectively Inhibits IL-12-Induced Stat4 Phosphorylation in T Lymphocytes

The Journal of immunology (1950), 2000-02, Vol.164 (4), p.1768-1774

2000

Volltextzugriff (PDF)

Tumor Necrosis Factor α Decreases, and Interleukin-10 Increases, the Sensitivity of Human Monocytes to Dexamethasone: Potential Regulation of the Glucocorticoid Receptor

The journal of clinical endocrinology and metabolism, 1999-08, Vol.84 (8), p.2834-2839

1999

Volltextzugriff (PDF)

Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha

The Journal of immunology (1950), 2002-03, Vol.168 (5), p.2212-2218

2002

Volltextzugriff (PDF)

Association of PNPLA3 (rs738409 C>G) with liver damage in liver diseases: one step closer to personalized medicine?

Personalized medicine, 2011-11, Vol.8 (6), p.595-597

2011

Volltextzugriff (PDF)

CD47low status on CD4 effectors is necessary for the contraction of the immune response in humans and mice (69.13)

The Journal of immunology (1950), 2012-05, Vol.188 (1_Supplement), p.69-69.13

2012

Volltextzugriff (PDF)

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

Acta gastro-enterologica belgica, 2015-01, Vol.78 (1), p.26-29

2015

Volltextzugriff (PDF)

The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)

Acta gastro-enterologica belgica, 2011-09, Vol.74 (3), p.421-426

2011

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(41)
Französisch
(8)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Segmental arterial mediolysis and its mimickers: a case report and review of the literature

Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection

Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases

Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study

Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)

Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis

Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases

Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID

A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103− dendritic cells

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

Abstract 4603: Clinical application and potential usefulness of targeted next-generation sequencing on resected pancreatic ductal adenocarcinoma

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF

Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists

Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response

Inhibition of Th1 Immune Response by Glucocorticoids: Dexamethasone Selectively Inhibits IL-12-Induced Stat4 Phosphorylation in T Lymphocytes

Tumor Necrosis Factor α Decreases, and Interleukin-10 Increases, the Sensitivity of Human Monocytes to Dexamethasone: Potential Regulation of the Glucocorticoid Receptor

Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha

Association of PNPLA3 (rs738409 C>G) with liver damage in liver diseases: one step closer to personalized medicine?

CD47low status on CD4 effectors is necessary for the contraction of the immune response in humans and mice (69.13)

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)

Aktive Filter

Suchergebnisse filtern